• Subscribe
  • Log In
  • Home
  • Daily Diary
  • Asset Class
    • U.S. Equity
    • Fixed Income
    • Global Equity
    • Commodities
    • Currencies
  • Sector
    • Basic Materials
    • Consumer Discretionary
    • Consumer Staples
    • Energy
    • Financial Services
    • Healthcare
    • Industrials
    • Real Estate
    • Technology
    • Telecom Services
    • Transportation
    • Utilities
  • Latest
    • Articles
    • Video
    • Columnist Conversations
    • Best Ideas
    • Stock of the Day
  • Street Notes
  • Authors
    • Doug Kass
    • Bruce Kamich
    • Jim Cramer
    • Jim "Rev Shark" DePorre
    • Helene Meisler
    • Jonathan Heller
    • - See All -
  • Options
  • RMPIA
  • Switch Product
    • Action Alerts PLUS
    • Quant Ratings
    • Real Money
    • Real Money Pro
    • Retirement
    • Stocks Under $10
    • TheStreet
    • Top Stocks
    • Trifecta Stocks
  1. Home
  2. / Investing

A Cheap and Profitable Screen

Finding super-value stocks that consistently beat the market.
By TIM MELVIN Sep 13, 2013 | 03:00 PM EDT
Stocks quotes in this article: MT, RSH, APOL, COCO, CECO

I reviewed the recent academic work of Robert Novy-Marx on Thursday. In his paper, "The Other Side of Value: Good Growth and the Gross Profitability Premium," the University of Rochester professor looked at historical returns from stocks with very high levels of gross profitability, and he found that they performed as well as stocks trading at a low price-to-book value. Combining the two types of stocks in your portfolio outperformed the market. Novy-Marx went even deeper and found that if you buy stocks below book value that also have high levels of gross profitability, you produce a portfolio of super-value stocks that consistently beat the market.

Being a bit of a skeptic, I conducted some quick back tests of his theory and found huge excessive returns. In the last year alone the big-cap, value-profitable stocks returned 45% while the small-cap stocks in the portfolio were up 54%. That is impressive performance, so I quickly built a screen that looked for cheap stocks that have very high gross profits compared to their asset base.

I found some surprises when I ran the screen. Some companies you might not think of as wildly profitable actually are when you measure them by gross profitability. Keep in mind that gross profitability is simply total sales minus cost of goods sold and leaves out all the overhead and other expenses. Novy-Marx found that this was the best measure of profitability and it has strong predicative value. So this the one we will use.

Arcelor Mittal (MT) is a large integrated steel company that one would not necessarily think of as wildly profitable as it has struggled in recent years. It took a bottom line loss in 2012 but managed to paint the bottom line black in the preceding decade. The CEO recently told investors that he believed the company had turned the corner and should see better conditions in the steel market in 2014. When we measure it in terms of gross profitability compared to assets, we find that the company has assets of $112 billion and gross profits over the last four quarters have been a little more than $74 billion. That is one of the cheapest ratios on the deep-value, high-profits screen. The stock is certainly cheap, trading at less than 60% of tangible book value.

I almost feel out of my chair I when saw RadioShack (RSH) on the list of cheap high-profit stocks. This has been a dog the past few years, and I was much too early buying it in anticipation of a turnaround or takeover. The company has its issues, but it also has a very high level of gross profitability with $1.4 billion of gross profits in the past year on an asset base of $1.9 billion. The stock is still cheap at 78% of book value, so if the company can find a way to improve the items between gross profits and the bottom line, my patience may yet be rewarded.

I was surprised that even though my credit and fundamental models use a lot more than one factor, the gross profitability and book-value combination picked out many companies I have mentioned on Real Money and own for myself, as well as for family and friends. Stocks including Kimball International (KBALB), Xyratex (XRTX), RealNetworks (RNWK) and SkyWest (SKYW) have very high gross profits as a percentage of assets. Trans World Entertainment (TWMC) is one of the stocks I hate to love as I believe brick-and-mortar music and video stores are an industry on the way out, but the stock has high gross profits as a percentage of assets and trades at just 85% of book value.

So do a couple of companies I have had my eye on but haven't purchased yet. Tropicana Entertainment is Carl Icahn's casino purchased out of bankruptcy a few years ago. It operates casinos in Nevada, Indiana, Louisiana, Mississippi, and New Jersey, as well as one in Aruba. The stock may not do much until Icahn decides to sell or otherwise transform the company, but it trades at just 3x gross profits and 80% of tangible book value.

I have not been a fan of the for-profit education business model, and Apollo Group (APOL) is one of the best shorts I have ever put on in my life. But many of the stocks in the group, such as Corinthian Colleges (COCO) and Career Education (CECO), are trading below book value and have high gross profits compared to assets. I haven't bought in yet, but the valuation is becoming compelling.

Using gross profits as a measure of profitability is clearly effective and should be an arrow in every investor's analytical quiver. When used with value stocks, it works extremely well at locating stocks that can survive and eventually thrive.

Get an email alert each time I write an article for Real Money. Click the "+Follow" next to my byline to this article.

At the time of publication, Melvin was long MT, KBALB, TWMC, RSH and RNWK.

TAGS: Investing | U.S. Equity

More from Investing

Marveling at the Market's Move? It's All About Momentum

James "Rev Shark" DePorre
Jan 19, 2021 4:41 PM EST

No news can explain the action -- whether the bears believe it or not.

Surface Oncology Is Set for Further Gains - How to Buy It

Bruce Kamich
Jan 19, 2021 3:25 PM EST

Here's our price objective.

My Preference With OneSpan Is Calls So I Can Define My Risk

Timothy Collins
Jan 19, 2021 2:36 PM EST

The last few post-earnings beat downs were greeted with optimism once traders got over the initial disappointment.

A Top Biotechnology Play for 2021

James "Rev Shark" DePorre
Jan 19, 2021 2:07 PM EST

Forte's sole clinic candidate is FB-401 for the treatment of atopic dermatitis, which is the scientific name for eczema.

Boot Barn Gets a Quant Upgrade: Do the Charts Fit?

Bruce Kamich
Jan 19, 2021 1:53 PM EST

Here's our latest analysis and trading strategy for the shares.

Real Money's message boards are strictly for the open exchange of investment ideas among registered users. Any discussions or subjects off that topic or that do not promote this goal will be removed at the discretion of the site's moderators. Abusive, insensitive or threatening comments will not be tolerated and will be deleted. Thank you for your cooperation. If you have questions, please contact us here.

Email

CANCEL
SUBMIT

Email sent

Thank you, your email to has been sent successfully.

DONE

Oops!

We're sorry. There was a problem trying to send your email to .
Please contact customer support to let us know.

DONE

Please Join or Log In to Email Our Authors.

Email Real Money's Wall Street Pros for further analysis and insight

Already a Subscriber? Login

Columnist Conversation

  • 11:09 AM EST GARY BERMAN

    Is Copper About to Turn to Rust?

    Below is a very long-term copper chart.  As you...
  • 08:02 AM EST GARY BERMAN

    Tuesday Morning Fibocall for for 1/19/2021

    SPX (Long-Term View) The 1/8/21 high @ 3826.69 i...
  • 09:01 AM EST JAMES "REV SHARK" DEPORRE

    This Weekend on Real Money

    When it's time to sell, will you act or freeze?
  • See More

COLUMNIST TWEETS

  • A Twitter List by realmoney
About Privacy Terms of Use

© 1996-2021 TheStreet, Inc., 225 Liberty Street, 27th Floor, New York, NY 10281

Need Help? Contact Customer Service

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data & Company fundamental data provided by FactSet. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by FactSet Digital Solutions Group.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

FactSet calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.

Compare Brokers

Please Join or Log In to manage and receive alerts.

Follow Real Money's Wall Street Pros to receive real-time investing alerts

Already a Subscriber? Login